Latest News about GILD
Recent news which mentions GILD
The Top 5 Stocks Cathie Wood Bought and Sold This Week
October 21, 2022
From InvestorPlace
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
October 21, 2022
Tickers
GILD
From Benzinga
From Benzinga
US Sends Gilead's COVID-19 Antiviral To Safeguard Health Workers In Uganda Ebola Outbreak
October 19, 2022
Tickers
GILD
From Benzinga
Europe Approves First CAR T-Cell Therapy For B-Cell Lymphoma In 30 Years to Improve Upon Standard of Care
October 18, 2022
Tickers
GILD
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
These 2 Growth Stocks Have Potential Catalysts on the Way
October 12, 2022
From Motley Fool
Want to Collect 4% in Dividends Every Month? Buy These 3 Stocks
October 12, 2022
From Motley Fool
4 Biotech Stocks With Huge Incoming Catalysts
October 12, 2022
From Motley Fool
Gilead's Trodelvy Under FDA Review For Pre-Treated HR+/HER2- Metastatic Breast Cancer
October 11, 2022
Tickers
GILD
From Benzinga
How to Find Stocks That Rise 10x
October 10, 2022
From InvestorPlace
Why This Gilead Analyst Believes The Stock Is Highly Undervalued
October 04, 2022
Tickers
GILD
From Benzinga
2 Top Biotech Stocks to Buy for the Long Haul
October 02, 2022
From Motley Fool
3 Biotech Stocks to Sell in October
September 29, 2022
From InvestorPlace
Vietnam Law May Impact Facebook, Twitter; Amazon Has A Sleep Tracker; India Lures Apple, Dell, HP: Top Financial Media Stories Thursday, Sept. 29
September 29, 2022
From Benzinga
Gilead's Investigation Reveals Two Kingpins Directly Associated With Fake HIV Medications Scheme
September 29, 2022
Tickers
GILD
From Benzinga
7 Monthly Dividend Stocks to Buy for Safety
September 29, 2022
From InvestorPlace
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
September 27, 2022
From InvestorPlace
Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond
September 23, 2022
From Motley Fool
Here's How Much $100 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today
September 20, 2022
Tickers
GILD
From Benzinga
Merck To Start New Islatravir HIV Trials With Lower Dose After FDA Hold
September 20, 2022
From Benzinga
"The Era of the Gene-Edited Human Is Here"
September 19, 2022
From Motley Fool
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
September 19, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.